This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Alexander disease is a progressive disorder characterized by macrocephaly, a frontal-occipital progression of MRI signal abnormalities, and the presence of Rosenthal fibers in the CNS.1-4⇓⇓⇓ Recently, Alexander disease has been associated with mutations in the glial fibrillary acidic protein (GFAP) gene, a member of the evolutionarily conserved intermediate filament (IF) family of genes.1-3⇓⇓ The authors describe rare findings in a case of infantile Alexander disease with rapid clinical deterioration and unique MRI progression in a patient with a novel GFAP mutation.
Case report.
A full-term boy of mixed Philippine and western European ancestry died at 38 days of life after prolonged seizures and respiratory failure. The mother had raised concerns about the neonate’s poor feeding on the first day of life. On day 5, the baby presented to the pediatrician with emesis and poor feeding. On day 9, the child was seen in an emergency room for emesis. On day 13, the child …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham